|
J Biol Chem, Vol. 275, Issue 14, 10323-10330, April 7, 2000
Sweet Tooth, a Novel Receptor Protein-tyrosine Kinase
with C-type Lectin-like Extracellular Domains*
Jack C.
Reidling ,
Michael A.
Miller, and
Robert E.
Steele§
From the Department of Biological Chemistry and the Developmental
Biology Center, University of California,
Irvine, California 92697-1700
 |
ABSTRACT |
A gene encoding a novel type of receptor
protein-tyrosine kinase was identified in Hydra vulgaris.
The extracellular portion of this receptor (which we have named
Sweet Tooth) contains four C-type lectin-like domains
(CTLDs). Comparison of the sequences of these domains with the
sequences of the carbohydrate recognition domains of various vertebrate
C-type lectins shows that Sweet Tooth CTLD1 and CTLD4 have
amino acids in common with those shown to be involved in carbohydrate
binding by the lectins. Comparison of sequences encoding CTLD1 from the
Sweet Tooth genes from different species of
Hydra shows variation in some of the conserved residues that participate in carbohydrate binding in C-type lectins. The Sweet Tooth gene is expressed widely in the
Hydra polyp, and expression is particularly high in the
endoderm of the tentacles. Treatment of polyps with peptides
corresponding to sequences in the Sweet Tooth CTLDs results
in the disintegration of the animal. These same peptides do not block
adhesion or morphogenesis of Hydra cell aggregates.
 |
INTRODUCTION |
Receptor protein-tyrosine kinases
(RTKs)1 are used to transduce
the signals required for a variety of developmental and physiological processes in multicellular animals (1). No RTKs have been identified in
unicellular organisms, and the yeast genome lacks sequences encoding
protein-tyrosine kinases (2). It is likely, therefore, that the
evolution of RTKs was a critical event in the formation of
multicellular animals. Because the bulk of characterized RTKs are from
a small number of triploblastic animal species, we have a relatively
restricted view of the evolutionary history of these molecules. It is
by no means clear that the classes of RTKs identified to date in higher
animals contain examples of all of the types of RTKs that multicellular
cellular animals have evolved. Sponges and cnidarians contain RTKs,
indicating that such receptors existed in the common ancestor of all
extant metazoans. A homologue of the vertebrate insulin receptor is
present in the cnidarian Hydra vulgaris (3), and a gene
encoding an RTK containing Ig-like domains in its extracellular portion
has been identified in a sponge (4, 5). These findings establish the
continuity of two types of RTKs from the earliest stages of metazoan
evolution through to vertebrates.
We know even less about the evolution of ligands for RTKs than we know
about the evolution of the receptors. Only a small number of RTK
ligands from invertebrate phyla have been characterized. All of the RTK
ligands that have been identified to date in both invertebrates and
vertebrates are proteins, although in some cases RTKs have been shown
to interact in a homophilic manner (6) and thus appear to lack a
separate ligand molecule. Notably lacking are examples of carbohydrates
as RTK ligands. Given the diversity of carbohydrates displayed on the
surfaces of animal cells, it is perhaps surprising that carbohydrates
appear not to have been exploited as ligands for RTK-mediated signaling
pathways. In searching for RTKs that play roles in developmental
processes in Hydra, we have identified a gene (Sweet
Tooth) encoding a novel RTK with an extracellular portion that
contains four C-type lectin-like domains (CTLDs). If the CTLDs of
Sweet Tooth bind carbohydrate, this receptor would be the
first example of an RTK that is activated by carbohydrate ligands.
Potential processes in which such a receptor could be involved include
cell adhesion, morphogenesis, and recognition of foreign cells. Peptide
blocking experiments with Hydra polyps suggest that
Sweet Tooth is not required for cell adhesion or morphogenesis. The possibility that Sweet Tooth acts as a
pattern recognition receptor for foreign cells and thus may be a
component of an immune system in Hydra cannot be ruled out.
 |
EXPERIMENTAL PROCEDURES |
Hydra Culture--
The various species and strains of
Hydra were obtained from the laboratory of Hans Bode
(University of California, Irvine, CA) and maintained according to
standard methods (7). The 105 strain of H. magnipapillata
was originally from the laboratory of Tsutomu Sugiyama. The UCI and
Basel strains of H. vulgaris, and the Swiss H. oligactis strain were originally from the laboratory of Pierre Tardent.
Isolation of Sweet Tooth cDNA Clones--
Amplification and
cloning of cDNA fragments from genes encoding protein-tyrosine
kinases were carried out essentially as described previously (3, 8).
Clones were screened by sequencing using only the dideoxy-T stop
reaction mixture (T-tracking). One of the amplified DNA fragments,
designated HTK27, was used to isolate several clones from a gt11
cDNA library prepared from adult polyps of H. vulgaris
(9). Sequence analysis of these clones revealed that they were
incomplete, consisting only of the portion of the cDNA encoding the
kinase domain. A fragment from the 5' end of one of the HTK27 clones
was then used to screen a ZAPII cDNA library made from whole
adult polyp poly(A)+ RNA (10). From this screen we obtained
clones from a new gene related to HTK27, which we termed Sweet
Tooth. Rescreening of the ZAPII cDNA library with a
Sweet Tooth probe yielded clones that in aggregate included
the entire Sweet Tooth coding sequence. Library screens and
DNA sequencing were carried out essentially as described previously
(3).
RNA Hybridization--
Poly(A)+ RNA was extracted
from adult H. vulgaris polyps using the Amersham Pharmacia
Biotech Quick Prep mRNA kit. Electrophoresis of the RNA in a
formaldehyde-agarose gel, transfer to a nylon filter, and hybridization
were carried out essentially as described previously (11).
Protein Expression in Yeast--
A fragment encoding the kinase
domain and carboxyl-terminal tail of Sweet Tooth (amino
acids 940-1348) was amplified from one of the cDNA clones using
primers that included a SalI cleavage site at the 5' end of
the 5' primer and an XbaI cleavage site at the 5' end of the
3' primer. The 5' primer also included an ATG codon, the eight
nucleotides upstream of the ATG in the GAL4 gene
(5'-CCTGAAAGATG-3'), and the following Sweet
Tooth sequence: 5'-TATCAAATGGGGTGTGATG-3'. The 3' primer contained
the following Sweet Tooth sequence:
5'-CGGCACGAGCGGCACGAG-3'. This sequence is located in the 3'
untranslated sequence of the gene. Amplification of the entire coding
region of the Src2 gene from Xenopus laevis (12)
was performed using gene-specific primers with BglII and XbaI cleavage sites attached to the 5' and 3' primers,
respectively. The amplified fragments were isolated from the reaction
mixtures with QIAEX particles (Qiagen), cleaved with the appropriate
restriction enzymes, and purified by agarose gel electrophoresis.
Fragments were ligated into the galactose-inducible yeast expression
vector pRS316-GAL1 (13), which had been cleaved with either
SalI and XbaI (for the Sweet Tooth
fragment) or BamHI and XbaI (for the Src2 fragment). Strain W303 of Saccharomyces
cerevisiae was transformed with plasmid DNA using the lithium
acetate method (14). Transformants were selected on minimal medium
lacking uracil. For expression of the Sweet Tooth and Src2 proteins,
plasmid-containing yeast cells were grown at 30 °C in uracil-minus
minimal medium plus glucose overnight and then diluted 1:250 in
uracil-minus minimal medium plus galactose and grown for an additional
20 h.
Cells were harvested by centrifugation, and proteins were extracted by
alkaline lysis (15). Protein concentrations were determined using the
BCA protein assay reagent kit (Pierce). Equal amounts of protein were
fractionated by SDS polyacrylamide gel electrophoresis and transferred
to an Immobilon-P filter (Millipore) using a Bio-Rad Trans-Blot SD
semidry electrophoretic transfer cell. The filter was blocked in 5%
bovine serum albumin for 1 h at room temperature and incubated
with 4G10 anti-phosphotyrosine antibody (Upstate Biotechnology) in
Tris-buffered saline plus 0.05% Tween 20 at a dilution of 1:13,000.
The filter was then washed at room temperature five times for 5 min
each in Tris-buffered saline plus 0.05% Tween 20. After incubation for
1 h at room temperature with a horseradish peroxidase-conjugated
goat anti-mouse IgG antibody (Transduction Laboratories) diluted
1:25,000 in Tris-buffered saline plus 0.05% Tween 20, the filter was
washed at room temperature four times for 5 min each in Tris-buffered
saline plus 0.05% Tween 20. Bound antibody was detected with the
SuperSignal chemiluminescent substrate for Western blotting (Pierce).
Amplification of CTLD1 Genomic Sequences--
Total DNA was
isolated from H. vulgaris (Basel and UCI strains), H. magnipapillata (105 strain), and H. oligactis (Swiss
strain) using a rapid extraction method (16). PCR primers were designed to amplify the DNA sequence encoding CTLD1. The 5' primer
sequence was 5'-TCCGGATCCGTAAGCAATAGCTGTGACA-3' and
included a BamHI cleavage site at the 5' end (underlined).
The 3' primer was 5'-GCAAGCTTTTTCTAATTTTACAAATAAATCC-3' and included a HindIII cleavage site at the 5' end
(underlined). These primers were used at a concentration of 100 pmol/µl with 100 ng of Hydra DNA as a template in a
100-µl reaction containing 1 × buffer (supplied with the
Taq DNA polymerase), 4 mM MgCl2, and
2.5 units of Taq DNA polymerase (Promega). The amplified DNA fragment was isolated by electrophoresis in a 3% NuSieve (FMC Bioproducts) agarose gel in Tris borate-EDTA buffer and extraction from
the gel using the Qiaex gel extraction kit (Qiagen). The isolated
fragment was cut with the restriction enzymes BamHI and HindIII, purified again by electrophoresis, and then
subcloned into pBluescript KS+ (48) that was cut with the same
restriction enzymes.
In Situ Hybridization--
Whole-mount in situ
hybridization to H. vulgaris polyps was carried out
essentially as described previously (17, 18). A mixture of three
digoxygenin-labeled RNA probes was used. Probes were made from cDNA
fragments encoding CTLDs 1, 3, and 4. To generate these fragments we
amplified with the following primers: CTLD1 (see above); CTLD3,
5' primer (5'-GCGGATCCAACAATACAAACTGTAG-3') and 3' primer,
(5'-GCAAGCTTAACTTTACAAATAAATCG-3'), and CTLD4, 5' primer
(5'-GCGGATCCACCAATGAATATTGCGCTG-3') and 3' primer
(5'-TCCAAGCTTGGCTTAGGTAAAGTTCTTC-3'). Each primer pair contained
a BamHI cleavage site in the 5' primer and a
HindIII cleavage site in the 3' primer.
DNA amplification was performed as described above for genomic DNAs,
except cDNA clones were used as the templates. The amplified DNA
fragments were cut with BamHI and HindIII,
purified using the Qiaex gel extraction kit (Qiagen), and then
subcloned into the pBluescriptII KS+ vector cleaved with
BamHI and HindIII. In vitro
transcription reactions using T7 and T3 polymerases (Promega), digoxygenin-UTP (Roche Molecular Biochemicals), and linearized plasmid
templates to yield sense and antisense probes were carried out
according to standard methods.
After in situ hybridization, polyps were permanently mounted
on microscope slides using Euparal (Asco Laboratories). Photographs were taken with an Olympus Vanox microscope using Nomarski optics and
Eastman Kodak Co. Ektachrome 160T film.
Synthetic Peptide Treatment--
Synthetic peptides were
synthesized that corresponded to a conserved eight-amino acid sequence
in each of the four CTLDs of Sweet Tooth (see Fig.
1B). In addition, a control peptide was synthesized that was
a scrambled version of the CTLD1 peptide. Peptide synthesis was
performed by Quality Controlled Biochemicals, Inc. All peptides were
amidated on the carboxyl terminus. The amino acid sequences of the
peptides are as follows: CTLD1, NYWIGLND-NH2; CTLD2,
FFWIGLNY-NH2; CTLD3, NYWIGLTD-NH2; CTLD4,
KYWIGLNK-NH2; and scrambled, LINGDYNW-NH2. The
peptides were received as acetate salts. Two milligrams of each peptide
were resuspended in 0.1% trifluoroacetic acid (TFA) in water for
purification using HPLC on a 10-mm Vydac C4 semipreparative column. The
peptides were eluted with a radient starting with 90 parts 0.1% TFA in
water and 10 parts 0.09% TFA in acetonitrile to 40 parts 0.1% TFA in water and 60 parts 0.09% TFA in acetonitrile. The flow rate was 3 ml/min. Peptide fractions were detected by UV absorbance at 280 nm. The
major absorbance peak samples were pooled, shell frozen, and
lyophilized to dryness. Samples were resuspended in 1 ml of Hydra medium and centrifuged at 1400 rpm in a
microcentrifuge to remove insoluble material. The supernatant was
transferred to a new tube, and its absorbance at 280 nm was measured.
The concentration of each peptide was determined from the absorbance using calculated molar extinction coefficients. Mass spectroscopy of
the collected fraction for the CTLD1 peptide was carried out to verify
that the HPLC purification was performing as expected. Purification was
successful for the peptides corresponding to CTLDs 1, 3, and 4. The
peptide for CTLD2 was insoluble in 0.1% TFA in water and therefore
could not be used for experiments.
The peptides were used at a concentration of 100 µM in
Hydra medium at 18 °C. Exposure of intact or regenerating
animals to peptides was carried out on groups of 10 animals in 1 ml of
medium in the well of a 24-well microtiter plate. A mixture of the
three peptides was tested as well as individual peptides. For control experiments either a scrambled version of the peptide for CTLD1 in
Hydra medium or Hydra medium alone was used.
Fresh peptide-containing medium was added daily during the course of
the experiment. Animals were fed 2 days before the start of peptide
treatment but were not fed during peptide treatment.
Aggregates of cells of the UCI strain of H. vulgaris were
prepared according to standard methods (19, 20). Peptides were added
both before and immediately after centrifugation of the cells to form
the aggregate. If the peptide was added before centrifugation, a 1-h
incubation at 18 °C with constant mild agitation was performed before centrifugation. Incubation was continuous after centrifugation, with three aggregates per well per 100 µl of solution in 96-well microtiter plates at 18 °C. Fresh peptide-containing medium was added 8, 24, and 32 h after aggregate formation.
 |
RESULTS |
The Sweet Tooth Gene Encodes a Receptor Protein-tyrosine Kinase
with Extracellular C-type Lectin-like Domains--
The organization of
the protein encoded by the Sweet Tooth gene is shown
schematically in Fig. 1A. The
protein contains a predicted signal peptide sequence at the amino
terminus, a predicted transmembrane sequence, and a typical
protein-tyrosine kinase catalytic domain. Phylogenetic comparison of
the Sweet Tooth catalytic domain sequence with sequences in
the data bases indicates that it is most closely related to members of
the subfamily of protein-tyrosine kinases that includes Ret, the
fibroblast growth factor receptors, and the platelet-derived growth
factor receptors and their relatives (data not shown). Comparison of
the sequence of the extracellular region of the Sweet Tooth
protein with the data bases yielded the unexpected finding that it
contains four CTLDs (Fig. 1A, CTLD1-CTLD4), a domain type
that has not been found in any other RTK. In addition, the
extracellular portion of the protein contains two divergent copies
(Fig. 1A, A and B) of a sequence with no
significant similarity to any sequences in the data base. An alignment
of the amino acid sequences of the predicted CTLDs from Sweet
Tooth with the CTLDs from various vertebrate C-type lectins is
shown in Fig. 1B. Phylogenetic analyses with the
extracellular and kinase domain sequences of Sweet Tooth do
not allow conclusions to be made regarding the evolutionary origin of
this gene. Construction of phylogenetic trees using a variety of CTLD
sequences shows that the four CTLDs of Sweet Tooth are more
closely related to each other than to other CTLDs (data not shown).
Although the sequence of the kinase domain of Sweet Tooth is
more closely related to those of the Ret, fibroblast growth factor, and
platelet-derived growth factor RTK families than to other RTK kinase
domains, phylogenetic analysis does not support a close evolutionary
relationship between Sweet Tooth and the members of these
families (data not shown). The RTKs of C. elegans, all of
which are now known because of completion of the genome sequence, do
not include any that contain CTLDs (21).

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
A, domain structure of the predicted
Sweet Tooth protein from H. vulgaris (UCI strain). The
signal peptide and transmembrane domain are indicated by black
boxes. The two portions of the kinase domain are indicated by
cross-hatched boxes. The four putative carbohydrate
recognition domains are indicated by the boxes labeled
CTLD1-CTLD4. The two copies of the repeated sequence in the
extracellular domain are indicated by boxes A and
B. B, amino acid sequences of the Sweet
Tooth CTLDs aligned with CRD sequences from vertebrate C-type
lectins. Amino acids present in a majority of the sequences are
boxed. The abbreviations and references for the vertebrate
sequences are as follows: MR CRD5, CRD5 from the human
macrophage mannose receptor; MBP-A, rat mannose-binding
protein A (45); ASGPR, rat asialoglycoprotein receptor (46);
and E-selectin (47). The alignment was carried out using
CLUSTAL as implemented by the Megalign program of the LASERGENE package
(DNASTAR). Dots under the sequences indicate the positions
of residues that have been shown to participate in the binding of the
site 2 calcium ion in MBP-A (22). The bar indicates the
sequences contained in the synthetic peptides used in the blocking
experiments.
|
|
C-type lectin domains contain a characteristic pattern of cysteine
residues as well as additional highly conserved residues (22). All of
the cysteines are conserved in the four CTLDs of Sweet Tooth
as are virtually all of the conserved residues (Fig. 1B). Of
particular interest are residues that have been shown to be involved in
coordinated binding of calcium and mannose in mannose-binding protein A
(MBP-A; Ref. 22). This binding involves the 5 residues indicated by
dots in Fig. 1B. Four of these 5 residues, as
well as the proline separating the first two of the residues (EPN), are
conserved in CTLD1 of Sweet Tooth. The replacement of
glutamic acid by lysine at the first of these positions in CTLD1 of
Sweet Tooth replaces a negative, calcium binding carboxyl group with a positively charged amino group. This would preclude an
interaction of this residue with calcium. Whether it is sufficient to
exclude calcium binding and/or carbohydrate binding by CTLD1 is not
known. CTLDs 2 and 3 show significant deviations at the five calcium
and carbohydrate binding positions and would thus seem less likely to
bind carbohydrate in a calcium-dependent manner. CTLD4
contains the sequence QPD instead of EPN at positions 94-96. This
sequence occurs in the asialoglycoprotein receptor, which recognizes
galactose, and has been shown to alter the specificity of MBP-A to
galactose when it replaces the EPN sequence in MBP-A (23, 24). In
addition, CTLD4 also contains the other residues involved in calcium
and carbohydrate binding with the exception of a substitution of serine
for asparagine at position 113. This substitution would potentially
provide the serine hydroxyl group for calcium coordination. Taken
together, the sequence data suggest that CTLD1 and CTLD4 are good
candidates for binding carbohydrate and that CTLD4 may recognize galactose.
Hybridization of poly(A)+ RNA from adult Hydra
polyps with a probe mixture specific for the sequence encoding the
extracellular portion of Sweet Tooth detects a single 4.4-kb
RNA species (Fig. 2). Assuming the
presence of a poly(A) tail of 100-200 nucleotides, the RNA is the size
expected from the sequence of the cDNA (4202 nucleotides).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Hybridization of Sweet Tooth
RNA. Poly(A)+ RNA (2 µg) from adult H. vulgaris polyps was probed with a mixture of cDNA fragments
encoding the extracellular portion of Sweet Tooth. The
positions of RNA size markers (Life Technologies) that were
electrophoresed in the same gel with the Hydra RNA are
indicated.
|
|
Evolution of a Sweet Tooth CTLD--
To explore the evolution of
the Sweet Tooth gene, we amplified the sequences encoding
CTLD1 from genomic DNA from another strain of H. vulgaris
(Basel strain) and from two other species of Hydra (H. magnipapillata and H. oligactis). In all three of the
amplified fragments an intron was located at a position identical to
that in the CTLD1 sequence from the UCI strain of H. vulgaris (data not shown), supporting the conclusion that the
fragments were from the Sweet Tooth gene in each case. An
alignment of the predicted amino acid sequences for CTLD1 from the UCI
and Basel strains of H. vulgaris and H. magnipapillata and H. oligactis is shown in Fig.
3. As expected from previous phylogenetic
analyses of these species,2
the H. magnipapillata sequence is more closely related to
the H. vulgaris sequences than is the H. oligactis sequence. Of particular interest is the fact that the
sequence that is expected to be involved in carbohydrate selectivity in
CTLD1 of H. vulgaris (KPN) contains potentially significant
changes in H. oligactis (RPD). This finding suggests that if
CTLD1 binds carbohydrate, it may bind a different carbohydrate in
H. oligactis than in H. vulgaris and H. magnipapillata. We were unable to amplify DNA from H. utahensis or H. viridissima using the primers that were
used for H. magnipapillata and H. oligactis. This
was not unexpected, because H. utahensis and H. viridissima are more distantly related to H. vulgaris
than are H. magnipapillata and H. oligactis.2

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
Predicted amino acid sequences of CTLD from
the Sweet Tooth genes of H. magnipapillata, H. oligactis, and the UCI and Basel strains of H. vulgaris. Amino acids identical to those in the
sequence of the UCI strain are boxed. The amino-terminal
sequence VSNSCD and the carboxyl-terminal sequence GFICKIRK were
encoded by the primers used for amplification.
|
|
Sweet Tooth Has Protein-tyrosine Kinase Activity--
To verify
that Sweet Tooth is an active protein-tyrosine kinase, we
expressed the kinase domain in the yeast S. cerevisiae. The
absence of typical protein-tyrosine kinases in yeast (2) makes it a
useful system for demonstrating protein-tyrosine kinase activity of
heterologous proteins (12). Yeast containing a plasmid with the
sequence encoding the Sweet Tooth kinase domain under control of the Gal4 promoter were grown in glucose and then transferred to galactose to induce expression of the Sweet Tooth
protein. Protein-tyrosine kinase activity in the yeast cells was
assayed by immunoblotting with an anti-phosphotyrosine antibody. An
extract from the galactose-induced cells containing the Sweet
Tooth kinase domain showed numerous phosphotyrosine-containing
proteins (Fig. 4, lane 6),
which were absent from cells grown in glucose (Fig. 4, lane
5). These results show that Sweet Tooth has the
potential to be a ligand-activated protein-tyrosine kinase.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 4.
The kinase domain of Sweet Tooth
is catalytically active. The Sweet Tooth kinase
domain was produced in yeast, and its activity was assayed by
immunoblotting of total yeast protein with an anti-phosphotyrosine
antibody. The Src2 gene of Xenopus laevis, which
has previously been shown to produce catalytically active protein in
yeast (12), was used as a positive control. Uninduced cells were grown
in glucose. Induced cells were grown in galactose. Lane 1,
vector only, uninduced; lane 2, vector only, induced;
lane 3, Src2, uninduced; lane 4,
Src2, induced; lane 5, Sweet Tooth,
uninduced; lane 6, Sweet Tooth, induced.
|
|
Expression of the Sweet Tooth Gene--
To examine the expression
pattern of the Sweet Tooth gene, whole-mount in
situ hybridization with adult Hydra polyps was carried out using a probe mixture specific for the region of the cDNA encoding the extracellular domain. Hybridization of the probe mixture
to poly(A)+ RNA from adult Hydra polyps showed
that it was specific for the Sweet Tooth gene, in that it
detected a single RNA species of the expected size (Fig. 2).
The hybridization pattern we observed for whole animals is shown in
Fig. 5A. The highest levels of
Sweet Tooth message were observed in endodermal cells of the
tentacles. The border of increased message level is located at the
junction between cells of the tentacle and cells of the head. There is
also a higher level of expression in the peduncle (the region between
the foot basal disc and the budding zone) compared with the rest of the
body column. A low level of expression is detected in the rest of the animal except in the foot basal disc cells, where expression is absent
(Fig. 5C). The head of Hydra can be divided into
two regions. The hypostome is the domed structure at whose apex the
mouth opening is located. The tentacle zone is located at the base of
the hypostome and consists of a ring of evenly spaced tentacles. To
obtain a clearer view of the Sweet Tooth expression pattern
in the head, we performed in situ hybridizations on
decapitated heads. The result of such a hybridization (Fig.
5B) confirmed the result seen with intact polyps. The high
level of RNA in the tentacle endoderm extends nearly the full length of
the tentacle, fading only at the tentacle tip (Fig. 5D).
From a higher-magnification view of the tentacle base it appears that
the increase in Sweet Tooth RNA level in the tentacle
endoderm occurs at least a few cells distal to the border between the
tentacle and the body column (Fig. 5E).

View larger version (77K):
[in this window]
[in a new window]
|
Fig. 5.
Expression of Sweet Tooth in
adult Hydra polyps detected by whole-mount
in situ hybridization analysis. A,
distribution of Sweet Tooth RNA in the whole adult polyp.
B, distribution of Sweet Tooth RNA in the
hypostome and tentacles. Animals were decapitated before in
situ hybridization. C, Sweet Tooth RNA
distribution in basal portion of the adult polyp. D, view
showing distribution of Sweet Tooth RNA in the tentacle.
E, view of a tentacle focusing on the hypostome-tentacle
border. F, Sweet Tooth RNA distribution in a
stage 5 bud. G, Sweet Tooth RNA distribution in a
bud between stages 6 and 7.
|
|
By examining the distribution of Sweet Tooth RNA during the
process of budding, Hydra's mode of asexual reproduction,
it was possible to determine when during tentacle formation the
Sweet Tooth RNA level rises. The level of Sweet
Tooth RNA begins to rise in the endoderm at the site of tentacle
formation at or shortly before the time when evagination of the
epithelial layers begins (Fig. 5F). Expression reaches its
maximal level before the completion of tentacle growth (Fig.
5G). Tentacle development during the process of head
regeneration was also examined with the same results (data not shown).
Effects of Treatment of Hydra with Peptides Predicted to Block
Sweet Tooth Ligand Binding--
To explore possible roles of
Sweet Tooth in Hydra, we treated animals with
synthetic peptides expected to block ligand binding. The peptides were
designed based on previously published work examining the importance of
amino acid residues 48-63 in the carbohydrate recognition domain (CRD)
of selectins (25-27). Mutation of tyrosine 48 in the CRD of E-selectin
to a phenylalanine abolishes carbohydrate binding (26). A synthetic
peptide corresponding to the conserved residues 48-55 of E-, L-, and
P-selectins (YYWIGIRK) was found to block the binding of all three
selectins in both cell culture and animal systems (25). A synthetic
peptide corresponding to residues 54-63 of any of the three selectins
blocked binding of neutrophils to P-selectin (27).
Peptides containing the Sweet Tooth CTLD sequences
corresponding to amino acids 48-53 of the E-selectin CRD (indicated in Fig. 1) were synthesized and purified by HPLC. In addition a scrambled version (LINGDYNW) of the CTLD1 peptide was produced. The peptide corresponding to CTLD2 was insoluble under the conditions we used and
was eliminated from our studies. After ~10 days of treatment with
peptide at a concentration of 100 µM, animals began to
lose cells rapidly, whereas controls in Hydra medium alone
or treated with the scrambled peptide did not. Small piles of
individual cells began to accumulate around the bases of the animals.
After 10-11 days the tentacles began to shorten in length and swell at
the tips (Fig. 6, A-D). At 12 days the heads of the treated animals had begun to bloat, the tentacles
were reduced to small nubs (Fig. 6E), and many free cells
were floating around the animals. At 13 days the head had
disintegrated, yet the foot remained largely intact (Fig.
6F). The animals disintegrated completely after ~14 days
(Fig. 6G). The CTLD4 peptide had the most rapid effect, with animals showing signs of cell loss and tentacle shrinkage 24-36 h
before animals treated with the peptides for CTLD1 and CTLD3. If all
three peptides were mixed, the time course of disintegration was the
same as that for the CTLD4 peptide alone. Animals treated exactly as
the experimental animals, but without peptides, and animals treated
with the control peptide were unaffected. Raising the concentration of
peptide to 1 mM only slightly accelerated the course of the
response.

View larger version (134K):
[in this window]
[in a new window]
|
Fig. 6.
Treatment of Hydra with
peptides from a Sweet Tooth CTLD. Representative
polyps that were treated with the CTLD4 peptide (KYWIGLNK) or the
control peptide (LLINGDYNW) at a concentration of 100 µM
are shown. A, apical portion of the tentacle of a polyp
treated for 14 days with the control peptide. B, apical
portion of the tentacle of a polyp treated for 14 days with the CTLD4
peptide. C, head region of a polyp treated for 14 days with
the control peptide. D, head region of a polyp treated for
11 days with the CTLD4 peptide. E, head region of a polyp
treated for 12 days with the CTLD4 peptide. F, polyp treated
with the CTLD4 peptide for 13 days; the head end of the polyp
(right) is disintegrating, whereas the foot basal disc
(lower left) remains intact. G, remains of an
animal after 14 days of treatment with the CTLD4 peptide.
|
|
The presence of a high level of Sweet Tooth RNA in tentacle
endodermal cells raised the possibility that Sweet Tooth may
play a role in tentacle development. To test this possibility we
attempted to block tentacle formation in regenerating animals and in
budding animals. Animals were decapitated immediately below the
tentacle zone and placed in peptide-containing medium. We also tested
the animals' ability to regenerate after preincubation in
peptide-containing medium for 5 days before decapitation. To analyze
the effects of the reagents on budding, we treated animals containing
stage 2-3 buds (28). It is during this stage in bud development that head structures begin to form. Exposure to peptides had no effect on
regeneration or budding; however, animals did disintegrate in the
manner described above after 14 days.
Sweet Tooth could act as an intercellular adhesion molecule.
The fact that peptide-treated animals eventually disintegrate could be
attributable to disruption of cell-cell adhesion. With Hydra
there is a direct test for the ability of cells to adhere, that being
the formation of aggregates of cells from dissociated animals. If
Hydra polyps are dissociated into individual cells in a mild
saline solution by gentle mechanical stimulation, the cells can be
centrifuged into aggregates that reform the ectodermal and endodermal
epithelial layers, regenerate heads and feet, and eventually separate
into complete animals (19).The complete morphogenesis of
Hydra polyps from aggregates occurs in 4-7 days (19, 29).
We added peptides before the final pelleting step in aggregate
formation. After a 1-h incubation in peptide-containing medium, cells
were pelleted and then transferred to fresh peptide-containing medium.
We saw no changes in aggregate development or morphology in the
presence of peptides. The animals did, however, disintegrate after 14 days.
 |
DISCUSSION |
As a result of the identification of RTK genes in the earliest
diverging animal phyla, we now know that the ancestor of all modern
metazoans contained signaling pathways activated by RTKs, but that such
receptors are likely absent from both plants and unicellular animals.
Studies with various model animal systems have revealed that RTKs play
critical roles in developmental processes and in the regulation of cell
division and physiology. The known RTK ligands are polypeptides, which
are either released into the intercellular mileu or anchored to the
surface of the cell. No RTKs have been identified that recognize
carbohydrates, despite the diversity of carbohydrate molecules
displayed on cell surfaces. Our identification of an RTK in
Hydra that contains CTLDs in its extracellular region
demonstrates that an RTK that potentially recognizes carbohydrates has
appeared in at least one animal phylum. Cnidaria, the phylum of which
Hydra is a member, diverged very early in the metazoan
radiation. Thus RTKs containing CTLDs were potentially present in the
last common ancestor of cnidarians and the rest of metazoans. If an RTK
with CTLDs was present in this ancestor and conserved during subsequent
stages of metazoan evolution, we would expect to find its progeny in
most modern animals. So far this has not been the case. Although C-type
lectins have been identified in a number of metazoan phyla, none has
been found to be an RTK. In C. elegans, the one case in
which we have a complete inventory of RTKs for an animal, no gene
encoding an RTK with CTLDs is present (21). However, C. elegans lacks several protein-tyrosine kinase genes that are
present in Hydra and vertebrates (30), indicating that some
genes have been lost in the lineage leading to C. elegans.
Although C. elegans lacks RTKs with CTLDs, a data base
search reveals that the nematode genome contains a number of genes
encoding proteins with CTLDs. Before the cloning of the Sweet
Tooth gene, no CTLD-containing protein had been identified in a
diploblastic organism. Thus our data demonstrate that the CTLD arose
before the divergence of triploblasts and diploblasts. Until more
animal phyla are examined, we cannot say whether the linkage of CTLDs
to an RTK occurred only in the phylum Cnidaria or whether it will turn
out to be of more widespread occurrence.
A key piece of information necessary to understand the role of
Sweet Tooth in Hydra is the nature of the
ligand(s) that it recognizes. Although we currently lack this
information, the extracellular portion of Sweet Tooth has
the potential for a variety of interactions. Each CTLD is potentially
capable of binding to a distinct ligand. In addition, the A and B
repeats may also recognize ligands. Thus Sweet Tooth is
potentially capable of recognizing a number of different molecules. At
least two of the CTLDs (CTLDs 1 and 4) of Sweet Tooth have
features that suggest that they could bind carbohydrates. However, the
presence of a CTLD is not, in and of itself, sufficient to allow one to
conclude that the CTLD will bind carbohydrate. For example,
CTLD-containing proteins serve as antifreeze proteins in the
circulatory systems of some fish (31, 32). One of the families of
receptors on natural killer lymphocytes contains CTLDs, but it appears
that at least some of these domains recognize protein ligands rather
than carbohydrate ligands (33, 34). However, in the cases of CTLDs that
do not bind carbohydrates, the CTLD sequences are less conserved than is the case for the Sweet Tooth CTLDs. For example, the
CTLDs of natural killer cell receptors lack calcium binding site 2 (35). Although we have not yet identified ligands for Sweet
Tooth, we have demonstrated that its kinase domain is
catalytically active. Thus it is very likely that Sweet
Tooth responds to ligand binding by activating one or more signal
transduction pathways in the manner of other RTKs.
Given the possibility that Sweet Tooth is a receptor that is
activated by binding to one or more carbohydrate ligands, what roles
might it play in Hydra? Because of the simplicity of both the composition and organization of Hydra, the number of
possible roles for Sweet Tooth is relatively limited. Two
possibilities seem likely. First, Sweet Tooth may serve as
an adhesion molecule, with adhesion being achieved by binding of the
CTLDs to carbohydrates and/or proteins on adjacent cells. C-type
lectins are known to act as adhesion molecules. The selectins mediate
the binding of leukocytes to endothelial cells (36). Lecticans,
proteoglycans that contain a C-type lectin domain and bind sulfated
glycolipids (37), appear to play a role in cell adhesion in the nervous system (38). Our attempts to block adhesion of Hydra cells
with synthetic peptides corresponding to sequences in the Sweet
Tooth CTLDs were unsuccessful. This result suggests that
Sweet Tooth may not be involved in adherence of
Hydra cells to each other. Alternatively, adhesion could be
mediated by several different molecules, with any one molecule being
dispensible. A example of such redundancy among adhesion molecules is
seen in Drosophila, in which loss of function of fasciclin
I, a neural cell adhesion molecule, has no effect on development of the
nervous system (39).
In addition to testing for a role in adhesion, we also tested whether
the Sweet Tooth peptides could block regeneration of the
head, a process that requires adhesion as well as other morphogenetic processes. The high level of Sweet Tooth gene expression in
the tentacles and during tentacle formation suggests the possibility that it might be involved in morphogenetic processes associated with
tentacle formation. In Hydra, tissue displacement occurs continuously in the adult (40, 41). Cells from the body column are
continuously moving into the tentacles. Thus the morphological changes
associated with the conversion of body column tissue into tentacle
tissue occur continuously. In addition to cell shape changes, this
conversion almost certainly involves changes in cell adhesion.
Sweet Tooth is thus a reasonable candidate for mediating
such changes. To test this possibility, we carried out peptide
treatment on animals that were regenerating heads. The peptides had no
effect on the rate or course of regeneration. It has been demonstrated
that head regeneration can be perturbed by treatment with both peptides
and proteolytic fragments from extracellular matrix molecules (10, 42),
indicating that application of peptides to regenerating animals is an
appropriate method for testing whether a protein has a role in morphogenesis.
A third potential role for Sweet Tooth is in the recognition
of foreign cells. Hydra has been shown to carry out
xenorecognition. In heterografts of H. oligactis and
H. vulgaris the cells of each species phagocytose the cells
of the other species, with the ultimate outcome, over a period of
several weeks, being the removal of all of the H. vulgaris
cells from the grafted animal (43). C-type lectins have been shown to
be used extensively for immune responses in both vertebrates and
invertebrates (35, 44). Thus a lectin RTK is an attractive candidate
for mediating xenorecognition in Hydra. We could envision,
for example, that failure of Sweet Tooth to detect a
species-specific carbohydrate on a cell with which it comes in contact
could result in the registering of that cell as foreign and subsequent
action against that cell. It is thus intriguing that treatment of
Hydra with Sweet Tooth peptides results in the
disintegration of the animal and that CTLD1 from H. vulgaris and H. oligactis shows sequence differences that suggest
that they might recognize different carbohydrates.
 |
ACKNOWLEDGEMENTS |
We thank Hans Bode for many discussions of
this work and Haoping Liu for advice on yeast methods. We thank
Nam-Phuong Tran for help during the early stages of this project.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant R01-RR09755 (to R. E. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) L22612, AF129527, AF129528, and AF129529.
Portions of this work have been submitted in partial fulfillment
of the requirements for the Ph.D. degree in Biological Sciences at the
University of California, Irvine. Present address: Dept. of Biology,
University of California, Santa Cruz, CA 95064.
§
To whom correspondence should be addressed: Dept. of Biological
Chemistry, University of California, 240D Medical Sciences I, Irvine,
CA 92697-1700. Tel.: 949-824-7341; Fax: 949-824-2688; E-mail:
resteele@uci.edu.
2
P. Snow and L. Buss, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
RTK, receptor
protein-tyrosine kinase;
CTLD, C-type lectin-like domain;
CRD, carbohydrate recognition domain;
TFA, trifluoroacetic acid;
HPLC, high-pressure liquid chromatography;
MBP-A, mannose-binding protein
A.
 |
REFERENCES |
| 1.
|
van der Geer, P.,
Hunter, T.,
and Lindberg, R. A.
(1994)
Annu. Rev. Cell Biol.
10,
251-337[CrossRef]
|
| 2.
|
Hunter, T.,
and Plowman, G.
(1997)
Trends Biochem. Sci.
22,
18-22[Medline]
[Order article via Infotrieve]
|
| 3.
|
Steele, R. E.,
Lieu, P.,
Mai, N. H.,
Shenk, M. A.,
and Sarras, M. P., Jr.
(1996)
Dev. Genes Evol.
206,
247-259[CrossRef]
|
| 4.
|
Schacke, H.,
Rinkevich, B.,
Gamulin, V.,
Müller, I. M.,
and Müller, W. E.
(1994)
J. Mol. Recognit.
7,
273-276[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Schacke, H.,
Schroder, H. C.,
Gamulin, V.,
Rinkevich, B.,
Müller, I. M.,
and Müller, W. E.
(1994)
Mol. Membr. Biol.
11,
101-107[Medline]
[Order article via Infotrieve]
|
| 6.
|
Pulido, D.,
Campuzano, S.,
Koda, T.,
Modolell, J.,
and Barbacid, M.
(1992)
EMBO J.
11,
391-404[Medline]
[Order article via Infotrieve]
|
| 7.
|
Lenhoff, H. M.,
and Brown, R. D.
(1970)
Lab. Anim.
4,
139-154[Abstract/Free Full Text]
|
| 8.
|
Chan, T. A.,
Chu, C. A.,
Rauen, K. A.,
Kroiher, M.,
Tatarewicz, S. M.,
and Steele, R. E.
(1994)
Oncogene
9,
1253-1259[Medline]
[Order article via Infotrieve]
|
| 9.
|
Bosch, T. C. G.,
Unger, T. F.,
Fisher, D. A.,
and Steele, R. E.
(1989)
Mol. Cell. Biol.
9,
4141-4151[Abstract/Free Full Text]
|
| 10.
|
Sarras, M. P., Jr.,
Yan, L.,
Grens, A.,
Zhang, X.,
Agbas, A.,
Huff, J. K.,
St. John, P. L.,
and Abrahamson, D. R.
(1994)
Dev. Biol.
164,
312-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Shenk, M. A.,
Bode, H. R.,
and Steele, R. E.
(1993)
Development
117,
657-667[Abstract]
|
| 12.
|
Steele, R. E.,
Unger, T. F.,
Mardis, M. J.,
and Fero, J. B.
(1989)
J. Biol. Chem.
264,
10649-10653[Abstract/Free Full Text]
|
| 13.
|
Liu, H.,
Krizek, J.,
and Bretscher, A.
(1992)
Genetics
132,
665-673[Abstract]
|
| 14.
|
Ito, H.,
Fukuda, Y.,
Murata, K.,
and Kimura, A.
(1983)
J. Bacteriol.
153,
163-168[Abstract/Free Full Text]
|
| 15.
|
Yaffe, M. P.,
and Schatz, G.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4819-4823[Abstract/Free Full Text]
|
| 16.
|
Davis, R. W.,
Thomas, M.,
Cameron, J.,
John, T. P. S.,
Scherer, S.,
and Padgett, R. A.
(1980)
Methods Enzymol.
65,
404-411[Medline]
[Order article via Infotrieve]
|
| 17.
|
Grens, A.,
Mason, E.,
Marsh, J. L.,
and Bode, H. R.
(1995)
Development
121,
4027-4035[Abstract]
|
| 18.
| Martínez, D. E., Dirksen, M.-L., Bode, P. M.,
Jamrich, M., Steele, R. E., and Bode, H. R. (1997) Dev.
Biol. 523-536
|
| 19.
|
Gierer, A.,
Berking, S.,
Bode, H.,
David, C. N.,
Flick, K.,
Hansmann, G.,
Schaller, H.,
and Trenkner, E.
(1972)
Nat. New Biol.
239,
98-101[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Technau, U.,
and Holstein, T. W.
(1995)
Development
121,
1273-1282[Abstract]
|
| 21.
|
Ruvkun, G.,
and Hobert, O.
(1998)
Science
282,
2033-2041[Abstract/Free Full Text]
|
| 22.
|
Weis, W. I.,
Kahn, R.,
Fourme, R.,
Drickamer, K.,
and Hendrickson, W. A.
(1991)
Science
254,
1608-1615[Abstract/Free Full Text]
|
| 23.
|
Drickamer, K.
(1992)
Nature
360,
183-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Kolatkar, A. R.,
and Weis, W. I.
(1996)
J. Biol. Chem.
271,
6679-6685[Abstract/Free Full Text]
|
| 25.
|
Briggs, J. B.,
Oda, Y.,
Gilbert, J. H.,
Schaefer, M. E.,
and Macher, B. A.
(1995)
Glycobiology
5,
583-588[Abstract/Free Full Text]
|
| 26.
|
Erbe, D. V.,
Wolitzky, B. A.,
Presta, L. G.,
Norton, C. R.,
Ramos, R. J.,
Burns, D. K.,
Rumberger, J. M.,
Rao, B. N.,
Foxall, C.,
Brandley, B. K.,
and Lasky, L. A.
(1992)
J. Cell Biol.
119,
215-227[Abstract/Free Full Text]
|
| 27.
|
Geng, J.-G.,
Heavner, G. A.,
and McEver, R. P.
(1992)
J. Biol. Chem.
267,
19846-19853[Abstract/Free Full Text]
|
| 28.
|
Otto, J. J.,
and Campbell, R. D.
(1977)
J. Exp. Zool.
200,
417-428[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Bode, H. R.
(1974)
Am. Zool.
14,
543-550
|
| 30.
|
Steele, R. E.,
Stover, N. A.,
and Sakaguchi, M.
(1999)
Gene (Amst.)
239,
91-97[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Loewen, M. C.,
Gronwald, W.,
Sonnichsen, F. D.,
Sykes, B. D.,
and Davies, P. L.
(1998)
Biochemistry
37,
17745-17753[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Gronwald, W.,
Loewen, M. C.,
Lix, B.,
Daugulis, A. J.,
Sonnichsen, F. D.,
Davies, P. L.,
and Sykes, B. D.
(1998)
Biochemistry
37,
4712-4721[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Braud, V. M.,
Allan, D. S.,
O'Callaghan, C. A.,
Soderstrom, K.,
D'Andrea, A.,
Ogg, G. S.,
Lazetic, S.,
Young, N. T.,
Bell, J. I.,
Phillips, J. H.,
Lanier, L. L.,
and McMichael, A. J.
(1998)
Nature
391,
795-799[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Boyington, J. C.,
Riaz, A. N.,
Patamawenu, A.,
Coligan, J. E.,
Brooks, A. G.,
and Sun, P. D.
(1999)
Immunity
10,
75-82[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Weis, W. I.,
Taylor, M. E.,
and Drickamer, K.
(1998)
Immunol. Rev.
163,
19-34[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Bevilacqua, M. P.,
and Nelson, R. M.
(1993)
J. Clin. Invest.
91,
379-387
|
| 37.
|
Iozzo, R. V.
(1998)
Annu. Rev. Biochem.
67,
609-652[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Miura, R.,
Aspberg, A.,
Ethell, I. M.,
Hagihara, K.,
Schnaar, R. L.,
Ruoslahti, E.,
and Yamaguchi, Y.
(1999)
J. Biol. Chem.
274,
11431-11438[Abstract/Free Full Text]
|
| 39.
|
Elkins, T.,
Zinn, K.,
McAllister, L.,
Hoffmann, F. M.,
and Goodman, C. S.
(1990)
Cell
60,
565-575[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Campbell, R. D.
(1973)
J. Cell Sci.
13,
651-661[Abstract/Free Full Text]
|
| 41.
|
Campbell, R. D.
(1967)
J. Morphol.
121,
19-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Zhang, X.,
Hudson, B. G.,
and Sarras, M. P., Jr.
(1994)
Dev. Biol.
164,
10-23[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Bosch, T. C. G.,
and David, C. N.
(1986)
J. Exp. Zool.
238,
225-234[CrossRef]
|
| 44.
|
Vasta, G. R.,
Ahmed, H.,
and Quesenberry, M. S.
(1996)
in
New Directions in Invertebrate Immunology
(Söderhäll, K.
, Iwanaga, S.
, and Vasta, G. R., eds)
, pp. 189-227, SOS Publications, Fair Haven, NJ
|
| 45.
|
Drickamer, K.,
Dordal, M. S.,
and Reynolds, L.
(1986)
J. Biol. Chem.
261,
6878-6887[Abstract/Free Full Text]
|
| 46.
|
Leung, J. O.,
Holland, E. C.,
and Drickamer, K.
(1985)
J. Biol. Chem.
260,
12523-12527[Abstract/Free Full Text]
|
| 47.
|
Bevilacqua, M. P.,
Stengelin, S.,
Gimbrone, M. A., Jr.,
and Seed, B.
(1989)
Science
243,
1160-1165[Abstract/Free Full Text]
|
| 48.
|
Alting-Mees, M. A.,
Sorge, J. A.,
and Short, J. M.
(1992)
Methods Enzymol.
216,
483-495[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. N. David, N. Schmidt, M. Schade, B. Pauly, O. Alexandrova, and A. Bottger
Hydra and the Evolution of Apoptosis
Integr. Comp. Biol.,
August 1, 2005;
45(4):
631 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Engel, S. Oezbek, R. Engel, B. Petri, F. Lottspeich, and T. W. Holstein
Nowa, a novel protein with minicollagen Cys-rich domains, is involved in nematocyst formation in Hydra
J. Cell Sci.,
October 15, 2002;
115(20):
3923 - 3934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. King and S. B. Carroll
A receptor tyrosine kinase from choanoflagellates: Molecular insights into early animal evolution
PNAS,
December 18, 2001;
98(26):
15032 - 15037.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|